Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRN321 (Darbepoetin Alfa) for Anemia in Solid Tumors
NCT00359840Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Jul 2006
- Primary completion
- Sep 2007
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of darbepoetin alfa in anemia, sponsored by Kyowa Kirin. Started Jul 2006; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00359840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359840.